All Stories

  1. A step-by-step protocol based on data mining to explore purinergic signaling in glioblastoma
  2. Retinoic acid-induced alterations enhance eATP-mediated anti-cancer effects in glioma cells: Implications for P2X7 receptor variants as key players
  3. In-vivo measurement of the extracellular ATP concentration by bio-luminescence: The pmeLUC probe
  4. P2X7 a new therapeutic target to block vesicle-dependent metastasis in colon carcinoma: role of the A2A/CD39/CD73 axis
  5. P2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior
  6. P2X7 Variants in Pathophysiology
  7. The purinergic receptor P2X7 as a modulator of viral vector-mediated antigen cross-presentation
  8. Preclinical and clinical aspects of P2X receptors as a common route in different diseases: A meeting report
  9. The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia
  10. Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
  11. Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells
  12. The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk
  13. EU COST Action CA21130 PRESTO ‘P2X receptors as therapeutic targets’ inaugural meeting report
  14. P2X7-dependent exchange of extracellular microparticles and mitochondria by mouse microglia
  15. Emerging roles of purinergic signaling in anti-cancer therapy resistance
  16. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
  17. A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice
  18. A2A Receptor contributes to tumor progression in P2X7 null mice
  19. Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
  20. Administration of P2X7 Receptor Blockers in Oncological Experimental Models
  21. Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation
  22. The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
  23. P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells
  24. Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor
  25. Astrocytes‐derived extracellular vesicles in motion at the neuron surface: Involvement of the prion protein
  26. Editorial: Ion Channel Signalling in Cancer: From Molecular Mechanisms to Therapeutics
  27. The ATP/P2X7 axis is a crucial regulator of leukemic initiating cells proliferation and homing and an emerging therapeutic target in acute myeloid leukemia
  28. The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
  29. Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells
  30. Role of ATP in Extracellular Vesicle Biogenesis and Dynamics
  31. P2X7 Receptor in Hematological Malignancies
  32. P2X7 Variants in Oncogenesis
  33. Differential sensitivity of acute myeloid leukemia cells to daunorubicin depends on P2X7A versus P2X7B receptor expression
  34. Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells
  35. Editorial: Emerging Mechanisms in Purinergic Signaling: From Cell Biology to Therapeutic Perspectives
  36. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
  37. The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility
  38. Detection of Extracellular ATP in the Tumor Microenvironment, Using the pmeLUC Biosensor
  39. Role of the P2X7 receptor in tumor-associated inflammation
  40. Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine
  41. Involvement of P2X7 Receptors in the Osteogenic Differentiation of Mesenchymal Stromal/Stem Cells Derived from Human Subcutaneous Adipose Tissue
  42. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
  43. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells
  44. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
  45. Emerging Roles of Purinergic Signaling in Diabetes
  46. Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis
  47. The P2X7 receptor: A main player in inflammation
  48. ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
  49. P2X7 receptor orchestrates multiple signalling pathways triggering inflammation, autophagy and metabolic/trophic responses.
  50. Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells
  51. P2 receptors in cancer progression and metastatic spreading
  52. Extracellular purines, purinergic receptors and tumor growth
  53. new insights on the therapeutic potential of P2X7 antagonists in human pathology
  54. Emerging Roles of P2X Receptors in Cancer
  55. Editorial (Thematic Issue: Purinergic P2X Receptors: Physiological and Pathological Roles and Potential as Therapeutic Targets)
  56. The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
  57. Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
  58. Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
  59. P2X receptors: New players in cancer pain
  60. New intriguing roles of ATP and its receptors in promoting tumor metastasis
  61. Purinergic Signaling in Bone
  62. The P2X7 receptor is a key modulator of aerobic glycolysis
  63. First in vivo demonstration that P2X7 receptor is an oncogene
  64. role of P2X7 receptor in bone cancer and bone metastasis
  65. Purinergic signaling in giant cell formation
  66. The dominant-negative von Willebrand factor gene deletion p.P1127_C1948delinsR: molecular mechanism and modulation
  67. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor
  68. cAMP efflux from human trophoblast cell lines: a role for multidrug resistance protein (MRP)1 transporter
  69. P2X7: a growth-promoting receptor—implications for cancer
  70. Expression of the P2X7 Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis
  71. Somatostatin as a Regulator of First-Trimester Human Trophoblast Functions
  72. The P2X7 receptor: a key player in IL-1 processing and release
  73. Stimulation of Purinergic Receptors Modulates Chemokine Expression in Human Keratinocytes
  74. Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles
  75. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration
  76. Stimulation of P2 receptors causes release of IL-1β–loaded microvesicles from human dendritic cells
  77. Involvement of the Purinergic P2X7 Receptor in the Formation of Multinucleated Giant Cells
  78. The P2X7 Receptor: A Key Player in IL-1 Processing and Release
  79. P2X7 receptor: Death or life?
  80. Pseudoapoptosis Induced by Brief Activation of ATP-gated P2X7 Receptors
  81. Basal Activation of the P2X7 ATP Receptor Elevates Mitochondrial Calcium and Potential, Increases Cellular ATP Levels, and Promotes Serum-independent Growth
  82. The Antibiotic Polymyxin B Modulates P2X7 Receptor Function
  83. Enhanced P2X7 Activity in Human Fibroblasts From Diabetic Patients: A Possible Pathogenetic Mechanism for Vascular Damage in Diabetes
  84. Tyrosine Phosphorylation of HSP90 within the P2X7 Receptor Complex Negatively Regulates P2X7 Receptors
  85. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia
  86. Human Leukocyte Antigen-A,-B,-C and -DR Alleles and Soluble Human Leukocyte Antigen Class I Serum Level in Ménière's Disease
  87. Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor
  88. Homology modeling and active-site residues probing of the thermophilicAlicyclobacillus acidocaldariusesterase 2
  89. Overexpression and properties of a new thermophilic and thermostable esterase from Bacillus acidocaldarius with sequence similarity to hormone-sensitive lipase subfamily